- Active not recruitingPHASE3
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
This study is testing a new medication called deucravacitinib for active psoriatic arthritis. It compares the new drug to a dummy pill to see if it helps people feel better and if it's safe. It's for people new to certain treatments or who have tried one specific type before.
For: Psoriatic ArthritisUnited States · Argentina · Australia - RecruitingPHASE3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
This study, called REMAP-CAP, looks at different treatments for serious lung infections like pneumonia, flu, and COVID-19 in adults needing intensive care. It aims to find out which treatments work best to help patients recover.
For: Community-acquired Pneumonia, Influenza, COVID-19United States · Australia · Belgium - RecruitingPHASE3
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
This study is looking into a medicine called apremilast for children aged 2-17 with Behçet's disease who get recurring mouth ulcers. It aims to see if apremilast can help reduce these ulcers compared to a dummy medicine.
For: Behçet DiseaseFrance · Greece · Israel - RecruitingPHASE3
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
This study is looking into a medicine called apremilast for children and young people aged 5 to 17 who have a type of arthritis called juvenile psoriatic arthritis. It aims to see if this medicine works better than a dummy pill to reduce their arthritis symptoms.
For: Active Juvenile Psoriatic ArthritisAustria · Belgium · France